Small non-coding RNA landscape of extracellular vesicles from a post-traumatic model of equine osteoarthritis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 3,94 MB, PDF-dokument

  • James R. Anderson
  • Jacobsen, Stine
  • Marie Walters
  • Louise Bundgaard
  • Andreas Diendorfer
  • Matthias Hackl
  • Emily J. Clarke
  • Victoria James
  • Mandy J. Peffers

Extracellular vesicles comprise an as yet inadequately investigated intercellular communication pathway in the field of early osteoarthritis. We hypothesised that the small non-coding RNA expression pattern in synovial fluid and plasma would change during progression of experimental osteoarthritis. In this study, we conducted small RNA sequencing to provide a comprehensive overview of the temporal expression profiles of small non-coding transcripts carried by extracellular vesicles derived from plasma and synovial fluid for the first time in a posttraumatic model of equine osteoarthritis. Additionally, we characterised synovial fluid and plasma-derived extracellular vesicles with respect to quantity, size, and surface markers. The different temporal expressions of seven microRNAs in plasma and synovial fluid-derived extracellular vesicles, eca-miR-451, eca-miR-25, eca-miR-215, eca-miR-92a, eca-miR-let-7c, eca-miR-486-5p, and eca-miR-23a, and four snoRNAs, U3, snord15, snord46, and snord58, represent potential biomarkers for early osteoarthritis. Bioinformatics analysis of the differentially expressed microRNAs in synovial fluid highlighted that in early osteoarthritis these related to the inhibition of cell cycle, cell cycle progression, DNA damage and cell proliferation as well as increased cell viability and differentiation of stem cells. Plasma and synovial fluid-derived extracellular vesicle small non-coding signatures have been established for the first time in a temporal model of osteoarthritis. These could serve as novel biomarkers for evaluation of osteoarthritis progression or act as potential therapeutic targets.

OriginalsprogEngelsk
Artikelnummer901269
TidsskriftFrontiers in Veterinary Science
Vol/bind9
ISSN2297-1769
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
This study and JA were funded by the Horserace Betting Levy Board. MP was funded by Wellcome Trust Clinical Intermediate Fellowship (grant 107471/Z/15/Z). LB and the animal experiment were funded by the Independent Research Fund Denmark, Technology and Production Sciences (grant number DFF - 7017-00066, 2017) and Gerda and AageHaensch's Foundation. MW was funded by a Ph.D. scholarship jointly awarded by the University of Copenhagen, the Technical University of Denmark, and the Swedish University of Agricultural Science.

Publisher Copyright:
Copyright © 2022 Anderson, Jacobsen, Walters, Bundgaard, Diendorfer, Hackl, Clarke, James and Peffers.

ID: 319166033